日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Two phase 1 randomised studies investigating the safety and pharmacokinetics of bepranemab in healthy participants of different ethnicities

两项 1 期随机研究调查了 bepranemab 在不同种族健康受试者中的安全性和药代动力学

Buchanan, Tim J; Ewen, Colin; Rebollo Mesa, Irene; Germani, Massimiliano; Watanabe, Shikiko; Jose, Joby; Famodimu, Omobola; Colson, Anny-Odile; De Bruyn, Steven

Peripheral T cell lymphoma following CD19-targeted chimeric antigen receptor T cell therapy

CD19靶向嵌合抗原受体T细胞疗法后发生的外周T细胞淋巴瘤

Tatetsu, Hiro; Kato, Koji; Wada, Atsushi; Hirano, Taichi; Ueno, Shikiko; Miyasato, Yuko; Yamada, Asami; Shichijo, Takafumi; Higuchi, Yusuke; Ueda, Yujiro; Nosaka, Kisato; Mikami, Yoshiki; Karube, Kennosuke; Matsuoka, Masao; Yasunaga, Jun-Ichirou

Decreased PU.1 expression in mature B cells induces lymphomagenesis

成熟B细胞中PU.1表达降低诱导淋巴瘤发生

Endo, Shinya; Nishimura, Nao; Toyoda, Kosuke; Komohara, Yoshihiro; Carreras, Joaquim; Yuki, Hiromichi; Shichijo, Takafumi; Ueno, Shikiko; Ueno, Niina; Hirata, Shinya; Kawano, Yawara; Nosaka, Kisato; Miyaoka, Masashi; Nakamura, Naoya; Sato, Ai; Ando, Kiyoshi; Mitsuya, Hiroaki; Akashi, Koichi; Tenen, Daniel G; Yasunaga, Jun-Ichirou; Matsuoka, Masao; Okuno, Yutaka; Tatetsu, Hiro

Relationship between Serum Bortezomib Concentration and Emergence of Diarrhea in Patients with Multiple Myeloma and/or AL Amyloidosis

多发性骨髓瘤和/或 AL 淀粉样变性患者血清硼替佐米浓度与腹泻发生的关系

Yuki Fujimoto, Shikiko Ueno, Kazutaka Oda, Nao Gunda, Yumi Shimomura, Yuka Nishimura, Ayami Yamaguchi, Akari Kuwano, Yuki Ito, Yusuke Baba, Aina Nishigaki, Natsumi Michiwaki, Shota Uchino, Kayo Kurogi, Yawara Kawano, Masao Matsuoka, Hideyuki Saito, Yutaka Okuno, Hirofumi Jono

Novel p97/VCP inhibitor induces endoplasmic reticulum stress and apoptosis in both bortezomib-sensitive and -resistant multiple myeloma cells

新型 p97/VCP 抑制剂可诱导对硼替佐米敏感和耐药的多发性骨髓瘤细胞的内质网应激和细胞凋亡

Nao Nishimura, Mohamed O Radwan, Masayuki Amano, Shinya Endo, Eri Fujii, Hironori Hayashi, Shikiko Ueno, Niina Ueno, Hiro Tatetsu, Hiroyuki Hata, Yoshinari Okamoto, Masami Otsuka, Hiroaki Mitsuya, Masao Matsuoka, Yutaka Okuno

Maintenance and enhancement of human peripheral blood mobilized stem/progenitor cell engraftment after ex vivo culture via an HDACi/SALL4 axis (3465)

通过 HDACi/SALL4 轴维持和增强体外培养后人类外周血动员干细胞/祖细胞植入 (3465)

Hiro Tatetsu, Myriam Armant, Fei Wang, Chong Gao, Shikiko Ueno, Xi Tian, Alex Federation, Jun Qi, James Bradner, Daniel G Tenen, Li Chai

Isolated Pancreatic Myeloid Sarcoma Associated with t(8;21)/RUNX1-RUNX1T1 Rearrangement

与t(8;21)/RUNX1-RUNX1T1重排相关的孤立性胰腺髓系肉瘤

Tokunaga, Kenji; Yamamura, Ayako; Ueno, Shikiko; Kikukawa, Yoshitaka; Yamaguchi, Shunichiro; Hidaka, Michihiro; Matsuno, Naofumi; Kawaguchi, Tatsuya; Matsuoka, Masao; Okuno, Yutaka

Aberrant expression of SALL4 in acute B cell lymphoblastic leukemia: mechanism, function, and implication for a potential novel therapeutic target

急性 B 细胞淋巴细胞白血病中 SALL4 的异常表达:机制、功能及对潜在新治疗靶点的意义

Shikiko Ueno, Jiayun Lu, Jie He, Ailing Li, Xiaoxian Zhang, Jerome Ritz, Leslie E Silberstein, Li Chai

SALL4 is a key transcription regulator in normal human hematopoiesis

SALL4 是正常人类造血中的关键转录调节因子

Chong Gao, Nikki R Kong, Ailing Li, Hiro Tatetu, Shikiko Ueno, Youyang Yang, Jie He, Jianchang Yang, Yupo Ma, Grace S Kao, Daniel G Tenen, Li Chai

TRAIL produced from multiple myeloma cells is associated with osteolytic markers

多发性骨髓瘤细胞产生的 TRAIL 与溶骨标志物相关

Yawara Kawano, Shikiko Ueno, Masahiro Abe, Yoshitaka Kikukawa, Hiromichi Yuki, Kenichi Iyama, Yutaka Okuno, Hiroaki Mitsuya, Hiroyuki Hata